The bill would close legal loopholes that brand name drug companies have exploited to keep affordable generic drugs off the market.
American consumers are desperate for affordable prescription drugs.
This legislation is a significant step toward providing all consumers access to safe and affordable prescription drugs. The Greater Access to Affordable Pharmaceuticals Act will accelerate generic drug competition by removing incentives for brand name drug companies to pay off potential generic competitors, by requiring full and accurate listing of all relevant patents, by strengthening the citizen petition process, and by making it harder for brand name drug companies to delay FDA's approval process for generic drugs. U.S. PIRG is the national lobbying office for state-based Public Interest Research Groups across the country. The press release posted here has been provided to Common Dreams NewsWire by one of the many progressive organizations who make up America's Progressive Community . If you wish to comment on this press release or would like more information, please contact the organization directly.